Recruiting NCT07249671

Effects of Rope Skipping in Cardiopulmonary Fitness in Children

No phase Interventional Cardiopulmonary

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied: The protocol lists: Rope skipping, unsupervised free play.
Who it may be relevant to: Registry conditions: Cardiopulmonary. Basic parameters: 6 years — 12 years · All.
What needs checking: Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place: Pakistan
Next step: Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Effects of Rope Skipping in Cardiopulmonary Fitness in School Going Children

Overview

The study will be conducted in a school setting, involving a randomized control trial (RCT) of 178 children aged 6 to 12. The participants will be divided into two groups: a control group engaging in regular physical education (PE) classes and an experimental group practicing rope skipping for 50 minutes, three times a week, over a period of 8 weeks. Cardiopulmonary fitness will be assessed before and after the intervention using the borg rating scale and talk test of perceived exertion.. Data will be analyzed to determine changes in endurance, heart rate recovery, and lung function between the groups. The expected outcome is a significant improvement in cardiopulmonary parameters among the rope-skipping group, highlighting the exercise's effectiveness in promoting heart and lung health in children.

Detailed description

Physical inactivity among school-going children is a growing concern globally, leading to increased risks of cardiovascular diseases, obesity, and poor overall health. Cardiopulmonary fitness, an important indicator of a healthy heart and lungs, can significantly reduce these risks. Rope skipping, a simple yet effective exercise, is gaining attention as a potential intervention to enhance cardiopulmonary fitness in children. Its low cost, accessibility, and high intensity make it a feasible activity in school environments. This project investigates the impact of regular rope skipping on the cardiopulmonary fitness of school-going children, aiming to assess improvements in heart rate, endurance, and respiratory capacity. By evaluating these parameters, the study seeks to contribute to the growing body of evidence supporting physical activity as a crucial part of children's health routines.

Interventions

Other Rope skipping
Rope skipping exercise performed 50 minutes/ times ( including warm up and cool down session) 3 times / week for 8 weeks
Other unsupervised free play
The control group was engaged in self directed unsupervised free play.

Primary outcome measures

Borg rating scale [Time frame: duration 8 weeks]
Talk test of Perceived Exertion [Time frame: duration 8 weeks]
20 Meter Shuttle Run Test. [Time frame: duration 8 weeks]

Eligibility criteria

Inclusion criteria

School going children age 6 to 12 years
Children with no pre existing regular rope skipping training
No student athletes
Children with no physical and psychological disabilities

Exclusion criteria

Children with pre existing injuries
Children with chronic medical conditions
Children with cardiovascular issues
Children with disability

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation: Randomized
Model: Parallel assignment
Masking: Single blind
Primary purpose: Other

Study locations

Pakistan · 1 center

Allied school — Chak Four Hundred Fifty-four

Publications

Powell TA, Mysliwiec V, Brock MS, Morris MJ. OSA and cardiorespiratory fitness: a review. J Clin Sleep Med. 2022 Jan 1;18(1):279-288. doi: 10.5664/jcsm.9628. PMID 34437054

Identifiers

NCT: NCT07249671 · : REC/RCR&AHS/MOIZAKHAN

Primary sources (government registries)

ClinicalTrials.gov (US NIH)

View this study on ClinicalTrials.gov ↗